283.34 29.80 (11.75%)

99.56% Gain from 52W Low

3.1M XNAS Volume

High volume+gain today

XNAS 21 Mar, 2025 5:30 PM (EDT)

Target Upgrade
Scotiabank raises Alnylam's target price by 12% to $338 after it gets FDA nod for drug Amvuttra See details

Detailed Stock Analysis for Alnylam Pharmaceuticals Inc with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in